• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾原发性胆汁性肝硬化的自然病史及预后因素:一项长达18年的随访研究

Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.

作者信息

Su Chien-Wei, Hung Hung-Hsu, Huo Teh-Ia, Huang Yi-Hsiang, Li Chung-Pin, Lin Han-Chieh, Lee Pui-Ching, Lee Shou-Dong, Wu Jaw-Ching

机构信息

Department of Medicine, Division of Gastroenterology, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Liver Int. 2008 Nov;28(9):1305-13. doi: 10.1111/j.1478-3231.2008.01715.x. Epub 2008 Mar 13.

DOI:10.1111/j.1478-3231.2008.01715.x
PMID:18346129
Abstract

PURPOSE

The natural history of primary biliary cirrhosis (PBC) has been little studied in Asia. We conducted a Taiwanese cohort study on the natural history of PBC and analysed the prognostic factors.

METHODS

This study enrolled 96 consecutive PBC patients between 1985 and 2006 to evaluate the baseline characteristics and outcomes.

RESULTS

There were 74 females and 22 males. Eighty-five were positive for antimitochondrial antibodies in sera, and 11 were negative. The clinical manifestations and prognosis were similar between these two groups. In a median follow-up of 47.5+/-55.8 months, 27 patients died. Multivariate analysis indicated that the independent prognostic factors were serum albumin (P=0.021), creatinine (P=0.033) and ursodeoxycholic acid treatment (P=0.008). Besides, 42 patients developed adverse outcomes. Albumin (P<0.001), bilirubin (P=0.019) and prothrombin time (PT) (P=0.010) were significant factors. Moreover, a Mayo risk score <5, a Model for End-Stage Liver Disease (MELD) score <6, a Child-Pugh stage A and early liver histology were associated with favourable outcomes.

CONCLUSION

Serum albumin, bilirubin and PT were independent prognostic factors of adverse outcomes for Taiwanese PBC patients. Besides, the Mayo risk score, the MELD score, the Child-Pugh stage and liver histology were also validated to predict survival.

摘要

目的

原发性胆汁性肝硬化(PBC)的自然史在亚洲鲜有研究。我们开展了一项关于PBC自然史的台湾队列研究,并分析了预后因素。

方法

本研究纳入了1985年至2006年间连续的96例PBC患者,以评估其基线特征和结局。

结果

有74名女性和22名男性。85例患者血清抗线粒体抗体呈阳性,11例呈阴性。两组的临床表现和预后相似。中位随访47.5±55.8个月后,27例患者死亡。多因素分析表明,独立的预后因素为血清白蛋白(P = 0.021)、肌酐(P = 0.033)和熊去氧胆酸治疗(P = 0.008)。此外,42例患者出现不良结局。白蛋白(P < 0.001)、胆红素(P = 0.019)和凝血酶原时间(PT)(P = 0.010)是显著因素。此外,梅奥风险评分<5、终末期肝病模型(MELD)评分<6、Child-Pugh A期和早期肝脏组织学与良好结局相关。

结论

血清白蛋白、胆红素和PT是台湾PBC患者不良结局的独立预后因素。此外,梅奥风险评分、MELD评分、Child-Pugh分期和肝脏组织学也被证实可预测生存情况。

相似文献

1
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years.台湾原发性胆汁性肝硬化的自然病史及预后因素:一项长达18年的随访研究
Liver Int. 2008 Nov;28(9):1305-13. doi: 10.1111/j.1478-3231.2008.01715.x. Epub 2008 Mar 13.
2
Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.基于梅奥诊所预后模型的欧洲原发性胆汁性肝硬化人群中Pugh-Child-PBC分类患者的生存概率。欧洲原发性胆汁性肝硬化项目管理组。
Hepatogastroenterology. 1997 Jul-Aug;44(16):982-9.
3
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.原发性胆汁性肝硬化中的肝细胞癌及其对预后的影响。
Hepatology. 1997 Nov;26(5):1138-42. doi: 10.1002/hep.510260508.
4
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.对熊去氧胆酸有生化反应的原发性胆汁性肝硬化患者预后改善。
Gastroenterology. 2009 Apr;136(4):1281-7. doi: 10.1053/j.gastro.2009.01.003. Epub 2009 Jan 14.
5
Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.熊去氧胆酸治疗原发性胆汁性肝硬化患者的预后。一项涉及297例患者的10年队列研究结果。
Am J Gastroenterol. 2006 Sep;101(9):2044-50. doi: 10.1111/j.1572-0241.2006.00699.x. Epub 2006 Jul 18.
6
[Clinical features and prognosis of primary biliary cirrhosis in Korea].[韩国原发性胆汁性肝硬化的临床特征与预后]
Korean J Hepatol. 2010 Jun;16(2):139-46. doi: 10.3350/kjhep.2010.16.2.139.
7
Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study.与原发性胆汁性肝硬化死亡患者实际生存相关的主要临床事件、体征及严重程度评估分数。一项长期历史性队列研究。
Hepatogastroenterology. 1999 Jan-Feb;46(25):108-15.
8
New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.原发性胆汁性肝硬化的新简易预后评分:白蛋白-胆红素评分。
J Gastroenterol Hepatol. 2015 Sep;30(9):1391-6. doi: 10.1111/jgh.12938.
9
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?在熊去氧胆酸用于治疗原发性胆汁性肝硬化后,梅奥生存预测模型是否仍然有用?
Hepatology. 1996 May;23(5):1148-53. doi: 10.1002/hep.510230532.
10
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.儿童-普奇分类法和梅奥自然史模型在原发性硬化性胆管炎患者生存评估中的相对作用。
Hepatology. 1999 Jun;29(6):1643-8. doi: 10.1002/hep.510290607.

引用本文的文献

1
Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma.原发性胆汁性胆管炎与肝细胞癌的分子和临床关系的最新观点。
Int J Mol Sci. 2024 Feb 12;25(4):2194. doi: 10.3390/ijms25042194.
2
Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.原发性胆汁性胆管炎患者发生肝细胞癌的发病率:系统评价和荟萃分析。
Dig Dis Sci. 2021 Jul;66(7):2439-2451. doi: 10.1007/s10620-020-06498-7. Epub 2020 Aug 2.
3
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015.
中国原发性胆汁性胆管炎的流行病学和自然史:2000年至2015年香港地区的一项基于地域的研究
Clin Transl Gastroenterol. 2017 Aug 31;8(8):e116. doi: 10.1038/ctg.2017.43.
4
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.接受熊去氧胆酸治疗的中国原发性胆汁性胆管炎患者无移植生存的预后因素及预后模型验证
Clin Transl Gastroenterol. 2017 Jun 22;8(6):e100. doi: 10.1038/ctg.2017.23.
5
Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.中国患者原发性胆汁性肝硬化相关肝细胞癌:发病率及危险因素
World J Gastroenterol. 2015 Mar 28;21(12):3554-63. doi: 10.3748/wjg.v21.i12.3554.
6
Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者肝失代偿的风险因素。
World J Gastroenterol. 2013 Feb 21;19(7):1111-8. doi: 10.3748/wjg.v19.i7.1111.
7
Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in Chinese patients.中国患者抗线粒体抗体阳性原发性胆汁性肝硬化的预后因素和生存分析。
Dig Dis Sci. 2011 Sep;56(9):2750-7. doi: 10.1007/s10620-011-1661-7. Epub 2011 Mar 16.
8
Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China.南方地区成人年度健康体检人群原发性胆汁性胆管炎的患病率。
BMC Gastroenterol. 2010 Sep 3;10:100. doi: 10.1186/1471-230X-10-100.
9
Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.原发性胆汁性肝硬化患者17型辅助性T细胞与调节性T细胞失衡:血清细胞因子谱及外周细胞群
Clin Exp Immunol. 2009 May;156(2):217-25. doi: 10.1111/j.1365-2249.2009.03898.x. Epub 2009 Mar 2.